# US 6,730,735 B2 · Conjugate of polyethylene glycol and chitosan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,735 B2
- Document ID: US6730735B2
- Status: Granted
- Kind: B2
- Application number: 10/350,714
- Filed: 2003-01-24
- Published: 2003-09-04
- Granted: 2004-05-04
- Earliest claimed: 1997-07-03
- Assignees: West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited
- Inventors: Stanley Stewart Davis; Wu Lin; Fabio Bignotti; Paolo Ferruti
- Web page: https://patentgrep.com/patent/US6730735B2

## CPC

- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/5161: {Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin}
- A61K 9/5192: {Processes}
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- C08B 37/003: {Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof}
- C08G 81/00: Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers (involving only carbon-to-carbon unsaturated bond reactions C08F299/00 {; polyester-amides C08G69/44; polyester-imides C08G73/16; polyamides-imides C08G73/14; block- or graft polymers containing polysiloxane sequences C08G77/42})
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61K 9/0043: {Nose}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

PEG-chitosan conjugates comprising chitosan and polyethylene glycol moieties or derivatives thereof which are bonded together and their use in medicine is described. In one embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together via the amino function on the chitosan by the use of an activated chitosan species. In another embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together, the chitosan portion of the conjugate having a molecular weight in the range of from 10 kilodaltons to 1000 kilodaltons.

## Claims

### Claim 1

A composition for the systemic uptake of a drug across a mucosal membrane comprising a polyethylene glycol-chitosan conjugate, wherein the polyethylene glycol-chitosan conjugate comprises a chitosan or chitosan derivative moiety and a polyethylene glycol or a polyethylene glycol derivative moiety, and the composition is formulated for delivery to a mucosal membrane.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the chitosan or chitosan derivative moiety has a molecular weight of 10 kD to 1000 kD.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the chitosan or chitosan derivative moiety has a molecular weight of 20 kD to 500 kD.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the chitosan or chitosan derivative moiety has a molecular weight of 100 kD to 300 kD.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the polyethylene glycol-chitosan conjugate is represented by the formula (I):
—[Cm—NR12]p— (I)
wherein
Cm is a remainder of a monomeric unit of a chitosan or a chitosan derivative moiety;
p is an integer of 50 to 6000;
R1 is independently selected from a hydrogen atom and
wherein R2 is selected from a bond and a first divalent organic group; X is selected from an oxygen atom, a sulphur atom, and the group —NR3—, wherein R3 is selected from a hydrogen atom and a monovalent organic group; and [PEG] is a polyethylene glycol or polyethylene glycol derivative moiety,
provided that 1% to 99% of the groups represented by R1 is

### Claim 6 (depends on 5)

The composition of claim 5, wherein Cm is the remainder of the monomeric unit making up chitosan.

### Claim 7 (depends on 5)

The composition of claim 5, wherein p is an integer of 150 to 2,000.

### Claim 8 (depends on 5)

The composition of claim 5, wherein [PEG] is —R4—(OCH2CH2)n—, and R4 is a hydrocarbon group selected from the group consisting of an aliphatic hydrocarbon, an alicyclic hydrocarbon, and an aromatic hydrocarbon, and n is an integer of 10 to 1,000.

### Claim 9 (depends on 8)

The composition of claim 8, wherein R4 is an alkyl group.

### Claim 10 (depends on 8)

The composition of claim 8, wherein R4 is a methyl group.

### Claim 11 (depends on 5)

The composition of claim 5, wherein R2 is
wherein R5 is a divalent organic group that is bonded to the carbonyl group of R1.

### Claim 12 (depends on 5)

The composition of claim 5, wherein R2 is
and R6 is independently selected from a linear or a branched alkyl group having one to four carbon atoms and R7 is a divalent organic group.

### Claim 13 (depends on 11)

The composition of claim 11, wherein R5 is selected from the group consisting of
wherein R6 is independently selected from a linear or a branched alkyl group, and R7 is a divalent organic group; and
wherein each of R8, R9, R10, and R11 is independently selected from a hydrogen atom and a linear or branched alkyl group having one to three carbon atoms.

### Claim 14

A method for the preparation of a composition for the systemic uptake of a drug across a mucosal membrane comprising a polyethylene glycol-chitosan conjugate, the method comprising preparing the polyethylene glycol-chitosan conjugate by bonding the amino function of an activated chitosan species to a polyethylene glycol or polyethylene glycol derivative moiety.

### Claim 15 (depends on 14)

The method of claim 14, wherein the activated chitosan species is prepared using bis(acrylamide).
